p2a sequence Search Results


90
Eurofins t7 promoter, hhrbz sequence, piv-5 w3a leader sequence, mneongreen gene, p2a motif
T7 Promoter, Hhrbz Sequence, Piv 5 W3a Leader Sequence, Mneongreen Gene, P2a Motif, supplied by Eurofins, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/t7 promoter, hhrbz sequence, piv-5 w3a leader sequence, mneongreen gene, p2a motif/product/Eurofins
Average 90 stars, based on 1 article reviews
t7 promoter, hhrbz sequence, piv-5 w3a leader sequence, mneongreen gene, p2a motif - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GenScript corporation the p2a viral sequences
The P2a Viral Sequences, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/the p2a viral sequences/product/GenScript corporation
Average 90 stars, based on 1 article reviews
the p2a viral sequences - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Sangon Biotech nucleotide sequences his tag, p2a, and ha tag
Validation of the AKT-PROTAC-Reporter (APR) in U251 and 293T cells. (A) Left, the working principle of bimolecular fluorescence complementation (BiFC) technology based on EGFP; Right, a working diagram of a reporter dependent on PROTAC’s EGFP-based BiFC. (B) Schematic diagram of the plasmid <t>NEGFP-AKT1-P2A-CEGFP-CRBN</t> (EAEC). (C) HEK 293T cells with stable EAEC expression were treated with DMSO, MS1710 (1 μM), MS98 (2 μM), MS5033 (2 μM), or INY-03-041 (200 nM) for 12 h, and the intracellular green fluorescence was captured by fluorescence microscopy (20×). (D) The mean fluorescence intensity (MFI) at different time points after different PROTACs were used to treat U251 cells stably expressing EAEC. (E) The effects of DMSO and MS170 on stable overexpression of HA-EA and His-EC in U251 and 293T cells were studied. The protein immunoblotting results were representative of three independent replicates. After treatment with MS170, HA-EA could be significantly degraded, while His-EC showed no significant difference compared with control group. (F) Fluorescence microscopy (20×) was used to capture the change in the green fluorescence intensity of U251 and 293T cells with stable APR overexpression after treatment with DMSO and MS170 (1 μM) for 12 h. MS170 enables the APR to show microscopically captured green fluorescence inside cells. (G) U251 and 293T cells were digested and suspended, and then flow cytometry was used to further detect the change in the green fluorescence level after MS170 treatment. The proportion of fluorescent cells quantified in this experiment was based on the FITC channel signal intensity of 1 × 10 4 . ****: p < 0.0001, ***: p < 0.001, ns: not significant. Scale bars = 100 μm.
Nucleotide Sequences His Tag, P2a, And Ha Tag, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nucleotide sequences his tag, p2a, and ha tag/product/Sangon Biotech
Average 90 stars, based on 1 article reviews
nucleotide sequences his tag, p2a, and ha tag - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Obio Technology Corp Ltd gfbxo22 sequences vector plenti-u6-grna-mcmv- sacas9-p-2a-sfgfp
Validation of the AKT-PROTAC-Reporter (APR) in U251 and 293T cells. (A) Left, the working principle of bimolecular fluorescence complementation (BiFC) technology based on EGFP; Right, a working diagram of a reporter dependent on PROTAC’s EGFP-based BiFC. (B) Schematic diagram of the plasmid <t>NEGFP-AKT1-P2A-CEGFP-CRBN</t> (EAEC). (C) HEK 293T cells with stable EAEC expression were treated with DMSO, MS1710 (1 μM), MS98 (2 μM), MS5033 (2 μM), or INY-03-041 (200 nM) for 12 h, and the intracellular green fluorescence was captured by fluorescence microscopy (20×). (D) The mean fluorescence intensity (MFI) at different time points after different PROTACs were used to treat U251 cells stably expressing EAEC. (E) The effects of DMSO and MS170 on stable overexpression of HA-EA and His-EC in U251 and 293T cells were studied. The protein immunoblotting results were representative of three independent replicates. After treatment with MS170, HA-EA could be significantly degraded, while His-EC showed no significant difference compared with control group. (F) Fluorescence microscopy (20×) was used to capture the change in the green fluorescence intensity of U251 and 293T cells with stable APR overexpression after treatment with DMSO and MS170 (1 μM) for 12 h. MS170 enables the APR to show microscopically captured green fluorescence inside cells. (G) U251 and 293T cells were digested and suspended, and then flow cytometry was used to further detect the change in the green fluorescence level after MS170 treatment. The proportion of fluorescent cells quantified in this experiment was based on the FITC channel signal intensity of 1 × 10 4 . ****: p < 0.0001, ***: p < 0.001, ns: not significant. Scale bars = 100 μm.
Gfbxo22 Sequences Vector Plenti U6 Grna Mcmv Sacas9 P 2a Sfgfp, supplied by Obio Technology Corp Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gfbxo22 sequences vector plenti-u6-grna-mcmv- sacas9-p-2a-sfgfp/product/Obio Technology Corp Ltd
Average 90 stars, based on 1 article reviews
gfbxo22 sequences vector plenti-u6-grna-mcmv- sacas9-p-2a-sfgfp - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GenScript corporation p2a cleavage sequence
Validation of the AKT-PROTAC-Reporter (APR) in U251 and 293T cells. (A) Left, the working principle of bimolecular fluorescence complementation (BiFC) technology based on EGFP; Right, a working diagram of a reporter dependent on PROTAC’s EGFP-based BiFC. (B) Schematic diagram of the plasmid <t>NEGFP-AKT1-P2A-CEGFP-CRBN</t> (EAEC). (C) HEK 293T cells with stable EAEC expression were treated with DMSO, MS1710 (1 μM), MS98 (2 μM), MS5033 (2 μM), or INY-03-041 (200 nM) for 12 h, and the intracellular green fluorescence was captured by fluorescence microscopy (20×). (D) The mean fluorescence intensity (MFI) at different time points after different PROTACs were used to treat U251 cells stably expressing EAEC. (E) The effects of DMSO and MS170 on stable overexpression of HA-EA and His-EC in U251 and 293T cells were studied. The protein immunoblotting results were representative of three independent replicates. After treatment with MS170, HA-EA could be significantly degraded, while His-EC showed no significant difference compared with control group. (F) Fluorescence microscopy (20×) was used to capture the change in the green fluorescence intensity of U251 and 293T cells with stable APR overexpression after treatment with DMSO and MS170 (1 μM) for 12 h. MS170 enables the APR to show microscopically captured green fluorescence inside cells. (G) U251 and 293T cells were digested and suspended, and then flow cytometry was used to further detect the change in the green fluorescence level after MS170 treatment. The proportion of fluorescent cells quantified in this experiment was based on the FITC channel signal intensity of 1 × 10 4 . ****: p < 0.0001, ***: p < 0.001, ns: not significant. Scale bars = 100 μm.
P2a Cleavage Sequence, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p2a cleavage sequence/product/GenScript corporation
Average 90 stars, based on 1 article reviews
p2a cleavage sequence - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GenScript corporation p2a-dsred sequence synthesis
Validation of the AKT-PROTAC-Reporter (APR) in U251 and 293T cells. (A) Left, the working principle of bimolecular fluorescence complementation (BiFC) technology based on EGFP; Right, a working diagram of a reporter dependent on PROTAC’s EGFP-based BiFC. (B) Schematic diagram of the plasmid <t>NEGFP-AKT1-P2A-CEGFP-CRBN</t> (EAEC). (C) HEK 293T cells with stable EAEC expression were treated with DMSO, MS1710 (1 μM), MS98 (2 μM), MS5033 (2 μM), or INY-03-041 (200 nM) for 12 h, and the intracellular green fluorescence was captured by fluorescence microscopy (20×). (D) The mean fluorescence intensity (MFI) at different time points after different PROTACs were used to treat U251 cells stably expressing EAEC. (E) The effects of DMSO and MS170 on stable overexpression of HA-EA and His-EC in U251 and 293T cells were studied. The protein immunoblotting results were representative of three independent replicates. After treatment with MS170, HA-EA could be significantly degraded, while His-EC showed no significant difference compared with control group. (F) Fluorescence microscopy (20×) was used to capture the change in the green fluorescence intensity of U251 and 293T cells with stable APR overexpression after treatment with DMSO and MS170 (1 μM) for 12 h. MS170 enables the APR to show microscopically captured green fluorescence inside cells. (G) U251 and 293T cells were digested and suspended, and then flow cytometry was used to further detect the change in the green fluorescence level after MS170 treatment. The proportion of fluorescent cells quantified in this experiment was based on the FITC channel signal intensity of 1 × 10 4 . ****: p < 0.0001, ***: p < 0.001, ns: not significant. Scale bars = 100 μm.
P2a Dsred Sequence Synthesis, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p2a-dsred sequence synthesis/product/GenScript corporation
Average 90 stars, based on 1 article reviews
p2a-dsred sequence synthesis - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Azenta mouse trac*01 gene fused viral p2a sequence
Validation of the AKT-PROTAC-Reporter (APR) in U251 and 293T cells. (A) Left, the working principle of bimolecular fluorescence complementation (BiFC) technology based on EGFP; Right, a working diagram of a reporter dependent on PROTAC’s EGFP-based BiFC. (B) Schematic diagram of the plasmid <t>NEGFP-AKT1-P2A-CEGFP-CRBN</t> (EAEC). (C) HEK 293T cells with stable EAEC expression were treated with DMSO, MS1710 (1 μM), MS98 (2 μM), MS5033 (2 μM), or INY-03-041 (200 nM) for 12 h, and the intracellular green fluorescence was captured by fluorescence microscopy (20×). (D) The mean fluorescence intensity (MFI) at different time points after different PROTACs were used to treat U251 cells stably expressing EAEC. (E) The effects of DMSO and MS170 on stable overexpression of HA-EA and His-EC in U251 and 293T cells were studied. The protein immunoblotting results were representative of three independent replicates. After treatment with MS170, HA-EA could be significantly degraded, while His-EC showed no significant difference compared with control group. (F) Fluorescence microscopy (20×) was used to capture the change in the green fluorescence intensity of U251 and 293T cells with stable APR overexpression after treatment with DMSO and MS170 (1 μM) for 12 h. MS170 enables the APR to show microscopically captured green fluorescence inside cells. (G) U251 and 293T cells were digested and suspended, and then flow cytometry was used to further detect the change in the green fluorescence level after MS170 treatment. The proportion of fluorescent cells quantified in this experiment was based on the FITC channel signal intensity of 1 × 10 4 . ****: p < 0.0001, ***: p < 0.001, ns: not significant. Scale bars = 100 μm.
Mouse Trac*01 Gene Fused Viral P2a Sequence, supplied by Azenta, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse trac*01 gene fused viral p2a sequence/product/Azenta
Average 90 stars, based on 1 article reviews
mouse trac*01 gene fused viral p2a sequence - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GenScript corporation strongyloides-codonoptimized tetx sequence (strtetx)::p2a::mscarlet-i
Validation of the AKT-PROTAC-Reporter (APR) in U251 and 293T cells. (A) Left, the working principle of bimolecular fluorescence complementation (BiFC) technology based on EGFP; Right, a working diagram of a reporter dependent on PROTAC’s EGFP-based BiFC. (B) Schematic diagram of the plasmid <t>NEGFP-AKT1-P2A-CEGFP-CRBN</t> (EAEC). (C) HEK 293T cells with stable EAEC expression were treated with DMSO, MS1710 (1 μM), MS98 (2 μM), MS5033 (2 μM), or INY-03-041 (200 nM) for 12 h, and the intracellular green fluorescence was captured by fluorescence microscopy (20×). (D) The mean fluorescence intensity (MFI) at different time points after different PROTACs were used to treat U251 cells stably expressing EAEC. (E) The effects of DMSO and MS170 on stable overexpression of HA-EA and His-EC in U251 and 293T cells were studied. The protein immunoblotting results were representative of three independent replicates. After treatment with MS170, HA-EA could be significantly degraded, while His-EC showed no significant difference compared with control group. (F) Fluorescence microscopy (20×) was used to capture the change in the green fluorescence intensity of U251 and 293T cells with stable APR overexpression after treatment with DMSO and MS170 (1 μM) for 12 h. MS170 enables the APR to show microscopically captured green fluorescence inside cells. (G) U251 and 293T cells were digested and suspended, and then flow cytometry was used to further detect the change in the green fluorescence level after MS170 treatment. The proportion of fluorescent cells quantified in this experiment was based on the FITC channel signal intensity of 1 × 10 4 . ****: p < 0.0001, ***: p < 0.001, ns: not significant. Scale bars = 100 μm.
Strongyloides Codonoptimized Tetx Sequence (Strtetx)/P2a/Mscarlet I, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/strongyloides-codonoptimized tetx sequence (strtetx)::p2a::mscarlet-i/product/GenScript corporation
Average 90 stars, based on 1 article reviews
strongyloides-codonoptimized tetx sequence (strtetx)::p2a::mscarlet-i - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Twist Bioscience sequenced-based reagent ngomiv-p2a(codon-de-optimized)-his-58-gfp-nhei

Sequenced Based Reagent Ngomiv P2a(Codon De Optimized) His 58 Gfp Nhei, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sequenced-based reagent ngomiv-p2a(codon-de-optimized)-his-58-gfp-nhei/product/Twist Bioscience
Average 90 stars, based on 1 article reviews
sequenced-based reagent ngomiv-p2a(codon-de-optimized)-his-58-gfp-nhei - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Twist Bioscience sequenced-based reagent dhb-mng-p2a

Sequenced Based Reagent Dhb Mng P2a, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sequenced-based reagent dhb-mng-p2a/product/Twist Bioscience
Average 90 stars, based on 1 article reviews
sequenced-based reagent dhb-mng-p2a - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Beijing Genomics Institute Shenzhen p2a-mneongreen dna sequence

P2a Mneongreen Dna Sequence, supplied by Beijing Genomics Institute Shenzhen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p2a-mneongreen dna sequence/product/Beijing Genomics Institute Shenzhen
Average 90 stars, based on 1 article reviews
p2a-mneongreen dna sequence - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Bioneer Corporation dna sequence xbai-cxcl6-p2a-cxcl12 (sdf-1α)-bamhi

Dna Sequence Xbai Cxcl6 P2a Cxcl12 (Sdf 1α) Bamhi, supplied by Bioneer Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dna sequence xbai-cxcl6-p2a-cxcl12 (sdf-1α)-bamhi/product/Bioneer Corporation
Average 90 stars, based on 1 article reviews
dna sequence xbai-cxcl6-p2a-cxcl12 (sdf-1α)-bamhi - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Validation of the AKT-PROTAC-Reporter (APR) in U251 and 293T cells. (A) Left, the working principle of bimolecular fluorescence complementation (BiFC) technology based on EGFP; Right, a working diagram of a reporter dependent on PROTAC’s EGFP-based BiFC. (B) Schematic diagram of the plasmid NEGFP-AKT1-P2A-CEGFP-CRBN (EAEC). (C) HEK 293T cells with stable EAEC expression were treated with DMSO, MS1710 (1 μM), MS98 (2 μM), MS5033 (2 μM), or INY-03-041 (200 nM) for 12 h, and the intracellular green fluorescence was captured by fluorescence microscopy (20×). (D) The mean fluorescence intensity (MFI) at different time points after different PROTACs were used to treat U251 cells stably expressing EAEC. (E) The effects of DMSO and MS170 on stable overexpression of HA-EA and His-EC in U251 and 293T cells were studied. The protein immunoblotting results were representative of three independent replicates. After treatment with MS170, HA-EA could be significantly degraded, while His-EC showed no significant difference compared with control group. (F) Fluorescence microscopy (20×) was used to capture the change in the green fluorescence intensity of U251 and 293T cells with stable APR overexpression after treatment with DMSO and MS170 (1 μM) for 12 h. MS170 enables the APR to show microscopically captured green fluorescence inside cells. (G) U251 and 293T cells were digested and suspended, and then flow cytometry was used to further detect the change in the green fluorescence level after MS170 treatment. The proportion of fluorescent cells quantified in this experiment was based on the FITC channel signal intensity of 1 × 10 4 . ****: p < 0.0001, ***: p < 0.001, ns: not significant. Scale bars = 100 μm.

Journal: ACS Omega

Article Title: Dynamic Detection of the E3-PROTAC-Target Protein Ternary Complex In Vitro and In Vivo via Bimolecular Fluorescence Complementation

doi: 10.1021/acsomega.4c08186

Figure Lengend Snippet: Validation of the AKT-PROTAC-Reporter (APR) in U251 and 293T cells. (A) Left, the working principle of bimolecular fluorescence complementation (BiFC) technology based on EGFP; Right, a working diagram of a reporter dependent on PROTAC’s EGFP-based BiFC. (B) Schematic diagram of the plasmid NEGFP-AKT1-P2A-CEGFP-CRBN (EAEC). (C) HEK 293T cells with stable EAEC expression were treated with DMSO, MS1710 (1 μM), MS98 (2 μM), MS5033 (2 μM), or INY-03-041 (200 nM) for 12 h, and the intracellular green fluorescence was captured by fluorescence microscopy (20×). (D) The mean fluorescence intensity (MFI) at different time points after different PROTACs were used to treat U251 cells stably expressing EAEC. (E) The effects of DMSO and MS170 on stable overexpression of HA-EA and His-EC in U251 and 293T cells were studied. The protein immunoblotting results were representative of three independent replicates. After treatment with MS170, HA-EA could be significantly degraded, while His-EC showed no significant difference compared with control group. (F) Fluorescence microscopy (20×) was used to capture the change in the green fluorescence intensity of U251 and 293T cells with stable APR overexpression after treatment with DMSO and MS170 (1 μM) for 12 h. MS170 enables the APR to show microscopically captured green fluorescence inside cells. (G) U251 and 293T cells were digested and suspended, and then flow cytometry was used to further detect the change in the green fluorescence level after MS170 treatment. The proportion of fluorescent cells quantified in this experiment was based on the FITC channel signal intensity of 1 × 10 4 . ****: p < 0.0001, ***: p < 0.001, ns: not significant. Scale bars = 100 μm.

Article Snippet: After digestion of the vector with XbaI and Eco RI enzymes, the nucleotide sequences of the His tag, P2A, and HA tag were first synthesized on the treated vector by Sangon Biotech (Shanghai, China).

Techniques: Biomarker Discovery, Fluorescence, Plasmid Preparation, Expressing, Microscopy, Stable Transfection, Over Expression, Western Blot, Control, Flow Cytometry

Journal: eLife

Article Title: Visualizing the metazoan proliferation-quiescence decision in vivo

doi: 10.7554/eLife.63265

Figure Lengend Snippet:

Article Snippet: Sequenced-based reagent , NgoMIV-P2A(codon-de-optimized)-his-58-GFP-NheI , This study , Twist Biosciences , CATCCAAGCTCGGACATCGTGCCGGCGCGGGAAGTGGGGCCACGAACTTCAGTCTCCTCAAACAAGCCGGGGACGTCGAAGAGAACCCCGGGCCAATGCCACCAAAGCCATCTGCCAAGGGAGCCAAGAAGGCCGCCAAGACCGTCGTTGCCAAGCCAAAGGACGGAAAGAAGAGACGTCATGCCCGCAAGGAATCGTACTCCGTCTACATCTACCGTGTTCTCAAGCAAGTTCACCCAGACACCGGAGTCTCCTCCAAGGCCATGTCTATCATGAACTCCTTCGTCAACGATGTATTCGAACGCATCGCTTCGGAAGCTTCCCGTCTTGCTCATTACAACAAACGCTCAACGATCTCATCCCGCGAAATTCAAACCGCTGTCCGTTTGATTCTCCCAGGAGAACTTGCCAAGCACGCCGTGTCTGAGGGAACCAAGGCCGTCACCAAGTACACTTCCAGCAAGATGAGTAAAGGAGAAGAATTGTTCACTGGAGTTGTCCCAATCCTCGTCGAGCTCGACGGAGACGTCAACGGACACAAGTTCTCCGTCTCCGGAGAGGGAGAGGGAGACGCCACCTACGGAAAGCTCACCCTCAAGTTCATCTGCACCACCGGAAAGCTCCCAGTCCCATGGCCAACCCTCGTCACCACCTTCTGCTACGGAGTCCAATGCTTCTCCCGTTACCCAGACCACATGAAGCGTCACGACTTCTTCAAGTCCGCCATGCCAGAGGGATACGTCCAAGAGCGTACCATCTTCTTtAAGgtaagtttaaacatatatatactaactactgattatttaaattttcagGACGACGGAAACTACAAGACCCGTGCCGAGGTCAAGTTCGAGGGAGACACCCTCGTCAACCGTATCGAGCTCCAGgtaagtttaaacagttcggtactaactaaccatacatatttaaattttcagGGAATCGACTTCAAGGAGGACGGAAACATCCTCGGACACAAGCTCGAGTACAACTACAACTCCCACAACGTCTACATCATGGCCGACAAGCAAAAGAACGGAATCAAGGTCAACTTCAAGgtaagtttaaacatgattttactaactaactaatctgatttaaattttcagATCCGTCACAACATCGAGGACGGATCCGTCCAACTCGCCGACCACTACCAACAAAACACCCCAATCGGAGACGGACCAGTCCTCCTCCCAGACAACCACTACCTCTCCACCCAATCCGCCCTCTCCAAGGACCCAAACGAGAAGCGTGACCACATGGTCCTCCTCGAGTTCGTCACCGCCGCCGGAATCACCCACGGAATGGACGAGCTCTACAAGTCAGGAGCTAGCGGAGCCTACCCTTACGACG.

Techniques: Recombinant, Plasmid Preparation, Blocking Assay